Kestra Medical Technologies, Ltd. - Common Stock Share · BMG524411052 · KMTS (XNAS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview

AI-Powered Analysis

Fundamental Analysis

Find out what the numbers really say — before the market does

Analyze now

News Sentiment

Are today's headlines a buy signal or a red flag?

Analyze now

Buy / Hold / Sell

Should you Buy, Hold, or Sell? Get the AI verdict now.

Analyze now

Risk Assessment

Uncover hidden risks before they hit your portfolio.

Analyze now

Fair Value

Is this stock cheap, fairly priced, or overvalued?

Analyze now

Latest AI Analyses of Kestra Medical Technologies, Ltd. - Common Stock

Analyst Grade Summary

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

No Price

01.05.2026 20:37

Current Prices from Kestra Medical Technologies, Ltd. - Common Stock

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	KMTS	USD	01.05.2026 20:37	21,82 USD	1,10 USD +5,31 %
IEX	KMTS	USD	01.05.2026 19:59	21,79 USD	1,07 USD +5,16 %

Share Float & Liquidity

Free Float 56,10 %

Shares Float 32,74 M

Shares Outstanding 58,37 M

Company Profile for Kestra Medical Technologies, Ltd. - Common Stock Share

Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. Its Cardiac Recovery System platform is the ASSURE WCD, a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). The company's Cardiac Recovery System platform also includes a suite of integrated digital solutions and services that enable enhanced patient and provider engagement and oversight with the objective of improving patient outcomes. The company was founded in 2014 and is based in Kirkland, Washington.